Product Images Namenda
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Namenda NDC 67046-489 by Contract Pharmacy Services-pa, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image of Namenda chemical structure - bc6e059d 1951 4fa3 b904 230d4165724d 01
image of Figure 1: Time course of change graph - bc6e059d 1951 4fa3 b904 230d4165724d 02
image of Figure 2: Cumalative percentage graph - bc6e059d 1951 4fa3 b904 230d4165724d 03
This appears to be a chart displaying the Cumulative Percentage of Patients for a Placebo and NAMENDA with respect to the ADCS-ADL Change from Baseline. The chart displays two lines, one labeled "Placebo" and the other labeled "NAMENDA". The x-axis displays the ADCS-ADL Change from Baseline values, while the y-axis the Cumulative Percentage of Patients. At ADCS-ADL Change from Baseline equal to -5, the Cumulative Percentage of Patients is about 5 for Placebo and 20 for NAMENDA. At ADCS-ADL Change from Baseline equal to 25, the Cumulative Percentage of Patients is about 10 for Placebo and almost 25 for NAMENDA.*
image of Figure 3: Time course of the change graph - bc6e059d 1951 4fa3 b904 230d4165724d 04
This is a chart displaying the "SIB Score" with mean change from baseline, over 12 and 16-weeks of treatment with Placebo and NAMENDA. The third row reads "Clinical Decline".*
image of Figure 4: Cumulative percentage graph - bc6e059d 1951 4fa3 b904 230d4165724d 05
The text appears to be a graph showing the "Cumulative Percentage of Patients" on the Y axis and "SIB Change from Baseline" on the X axis. There are two lines, one labeled "Placebo" and the other labeled "NAMENDA". The graph shows the percentage of patients and change from baseline for each treatment option.*
image of Figure 5: Time course of the change graph - bc6e059d 1951 4fa3 b904 230d4165724d 06
image of Figure 6: Cumulative percentage graph - bc6e059d 1951 4fa3 b904 230d4165724d 07
The text represents a graph showing the cumulative percentage of patients who experienced a certain change in ADCS-ADL (Alzheimer's Disease Cooperative Study-Activities of Daily Living) score from baseline. The patients were either given a placebo or donepezil, or NAVENDA (an unknown drug) in combination with donepezil. The graph shows the change in percentage over time (-20 to 25) and the difference in results between the two treatment groups.*
image of Figure 7: Time course of the change graph - bc6e059d 1951 4fa3 b904 230d4165724d 08
This appears to be a figure or chart without any accompanying text describing its content. Therefore, a useful description cannot be generated.*
image of Figure 8: Cumulative percentage graph - bc6e059d 1951 4fa3 b904 230d4165724d 09
This appears to be a graph comparing the effects of two different treatments (Placebo/Donepezil and Namenda/Donepezil) on patients, measured by their SIB (Severe Impairment Battery) change from baseline. The Y-axis represents the "Cumulative Percentage of Patients" while the X-axis represents the SIB change from baseline, in increments from -30 to 25. Without further context or information, it is not possible to assess the significance of the results or the purpose of the study.*
10 mg - bc6e059d 1951 4fa3 b904 230d4165724d 10
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.